NEOADJUVANT CHEMOTHERAPY IN THE COMPLEX TREATMENT OF PATIENTS WITH STAGE IIIC - IV OVARIAN CANCER

被引：0
|
作者：
Kryzhanivska, Anna [1 ,2 ]
Djakiv, Iryna [1 ,2 ]
Hrytsyk, Roman [1 ]
机构：
[1] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine
[2] Ivano Frankivsk Redional Council, Prykarpatski Clin Oncol Ctr, Ivano Frankivsk, Ukraine
来源：
ANTICANCER RESEARCH | 2023年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01
引用
收藏
页码：3377 / 3377
页数：1
相关论文
共 50 条
  • [21] Primary cytoreductive surgery or neoadjuvant chemotherapy: A retrospective analysis of 214 patients with stage IIIc and IV ovarian, tubal and peritoneal cancer from the Norwegian Radium Hospital
    Silins, I., Sr.
    Elstrand, M. B.
    Davidson, B.
    Trope, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
    J. Alejandro Rauh-Hain
    Noah Rodriguez
    Whitfield B. Growdon
    A. K. Goodman
    David M. Boruta
    Neil S. Horowitz
    Marcela G. del Carmen
    John O. Schorge
    Annals of Surgical Oncology, 2012, 19 : 959 - 965
  • [23] Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer
    Rauh-Hain, I.
    Growdon, W.
    Rodriguez, N.
    Goodman, A.
    Boruta, D.
    Horowitz, N.
    Del Carmen, M.
    Schorge, J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S12 - S13
  • [24] Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
    Rauh-Hain, J. Alejandro
    Rodriguez, Noah
    Growdon, Whitfield B.
    Goodman, A. K.
    Boruta, David M., II
    Horowitz, Neil S.
    del Carmen, Marcela G.
    Schorge, John O.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) : 959 - 965
  • [25] Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC-IV Ovarian Cancer Survey Results from the Members of the European Society of Gynecological Oncology
    Cornelis, Sarah
    Van Calster, Ben
    Amant, Frederic
    Leunen, Karin
    van der Zee, Ate Gerard Jan
    Vergote, Ignace
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (03) : 407 - 416
  • [26] Prognostic impact of histological response after neoadjuvant chemotherapy in patients with stage IIIC/IV ovarian cancer undergoing complete cytoreductive surgery at the time of interval debulking surgery
    Morice, P.
    Ferron, J.
    Rey, A.
    Zafrani, Y.
    Uzan, C.
    Gouy, S.
    Castaigne, D.
    Duvillard, P.
    L'Homme, C.
    Pautier, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] SINGLE PORT ACCESS (SPA) ROBOT ASSISTED INTERVAL CYTOREDUCTION SURGERY WITH NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH STAGE IIIC-IV OVARIAN CANCER: FARGHALY'S TECHNIQUE
    Farghaly, Samir
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A288 - A288
  • [28] Racial disparities in women with stage IIIC and IV epithelial ovarian cancer receiving neoadjuvant chemotherapy versus primary debulking surgery: A National Cancer Database study
    Whitmore, G. T.
    Ramzan, A. A.
    Sheeder, J.
    Guntupalli, S. R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 121 - 122
  • [29] Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study.
    Loizzi, V
    Cormio, G
    Di Vagno, G
    Resta, L
    Cazzolla, A
    Di Gilio, A
    Cuccovillo, A
    Selvaggi, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 478S - 478S
  • [30] Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade serous ovarian cancer: Variation with neoadjuvant chemotherapy and prognostic value
    Barcena, C.
    Rojas, K.
    Lema, L.
    Manso Sanchez, L.
    Rios, J.
    Garcia-Martin, R.
    Maroto, A.
    Rodriguez-Peralto, J. L.
    Ciruelos Gil, E. M.
    Mendiola, D. C.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2017, 28
12345